Regular HIIT Exercise Enhances Health via Histamine

Men given high doses of two antihistamine drugs did not experience the same benefits of high intensity interval training that men on a placebo enjoyed, revealing some of the molecular underpinnings of exercise’s effect.

Written byRachael Moeller Gorman
| 4 min read
hiit high intensity interval training exercise histamine receptor fexofenadine ranitidine famotidine h1 h2 receptor

Register for free to listen to this article
Listen with Speechify
0:00
4:00
Share

ABOVE: Participants in the exercise study
THIBAUX VAN DER STEDE

Whether you’re peddling a bike, running on a treadmill, or hiking in the woods, regular aerobic exercise powerfully protects you from cardiovascular and metabolic disease. But the precise molecular mechanisms connecting regular activity to improved health have been unclear. A study published April 14 in Science Advances makes major gains in this understanding. Building off previous work on single bouts of exercise, researchers at Ghent University in Belgium found that when humans perform long-term training, histamine receptors are activated, improving a variety of cardiometabolic risk factors, from insulin sensitivity to aerobic capacity and blood vessel health.

“It’s awesome, it’s a very cool paper,” says University of Oregon exercise physiologist John Halliwill, who was not involved in the study. “This is one of a few studies out there finally looking at these molecular transducers, and this is the only one out there ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Related Topics

Meet the Author

  • After earning a bachelor’s degree in biology and neuroscience from Williams College, Rachael spent two years studying the tiny C. elegans worm as a lab tech at Massachusetts General Hospital/Harvard University. She then returned to school to get a master’s degree in environmental studies from Brown University, and subsequently worked as an intern at Scientific AmericanDiscover magazine, and the Annals of Improbable Research, the originators of the yearly Ig Nobel prizes. She now freelances for both scientific and lay publications, and loves telling the stories behind the science. Find her at rachaelgorman.com or on Instagram @rachaelmoellergorman.

    View Full Profile
Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies